Phytochemical and clinical studies of the bioactive extract of Glycyrrhiza glabra L. Family Leguminosae

Authors

  • Nagwa M. Ammar Pharmacognosy Department, National Research Centre, Dokki-12311, Cairo, Egypt
  • Siham S.El-Hawary Pharmacognosy Department, Faculty of Pharmacy, Cairo University, Egypt.
  • Amira A.El- anssary Pharmacognosy Department, National Research Centre, Dokki-12311, Cairo, Egypt
  • Nagwa Othman Department of oral diseases, Faculty of Dental Medicine, Cairo University, Egypt
  • Maha Galal Faculty of Dental Medicine, Misr University for Science and Technology (MUST).
  • Ahmed H. El-Desoky Pharmacognosy Department, National Research Centre, Dokki-12311, Cairo, Egypt.

Keywords:

Glycyrrhiza glabra, anti-inflammatory activity, bioactive constituents, clinical trial, gingivitis, plaque index

Abstract

The aim of this study was the isolation, identification of the bioactive ingredients of Glycyrrhiza glabra L. Family Leguminosae, as well as the evaluation of their efficacy and ability to control plaque induced gingivitis in a preliminary clinical study. The dried powdered roots and rhizomes of G. glabra was subjected to successive extraction using organic solvents of increasing polarity. The total polar extract of the roots and rhizomes of G. glabra showed significant inhibition of carrageenan induced swelling of the hind rat paw (P>0.5).Seven phenolic compounds namely liquiriteginin, liquiritin apioside, neoliquiritin apioside, isoliquiritin, isoliquritin apioside, licuraside2-(5-P-coumaryl apiosyl) and isoliquiritin were isolated from the total polar extract utilizing different chromatographic techniques (PC, TLC, CC, HPLC and LC/MS) and identified using spectral analysis (1H-NMR, 13C-NMR, 2D-NMR and ESI-MS).The effectiveness of the isolated bioactive fractions of G. glabra mouth rinse in the reduction of plaque and gingivitis was studied clinically, after the approval of its safety, and the results were significant

References

. Fine DH, Furgang D, Sinatra K,

Charles C, McGuire A, kumar LD. In

vivo antimicrobial effectiveness of

an essential oil contraining mouth

rinse 12hours after a single use and

days use.JClin

Periodontol.2005;32:335-40

. Blumenthal M, Goldberg A,

Brinckmann J. Herbal Medicine:

Expanded Commission E

Monographs. American Botanical

Council, Newton. 2000; 233–236.

. Ody P. The Complete Guide

Medicinal Herbal. The Royal

Horticultural Society. Dorling

Kindersley Limited Great

Britain.2000; 75.

. Nomura T, Fukai T, Akiyama T.

Chemistry of phenolic compounds of

licorice (Glycyrrhiza species) and

their estrogenic and cytotoxic

activities. Pure Appl Chem.

;74:1199–1206.

. Obolentseva GV, Litvinenko VI,

Ammosov AS, Popova TP,Sampiev

AM. Pharmacological and

therapeutic properties of licorice

preparations (a review).

Pharm.Chem. J. 1999;33:24-31.

. Murav'ev IA, Semenchenko VF.

Structure of triterpene saponins from

the roots of Glycyrrhiza echinata.

Chemistry of Natural Compounds.

; 5:13-14.

. Obukowicz MG, Welsch DJ,

Salsgiver WJ, Martin-Berger CL,

Chinn KS , Duffin KI, Raz A, Needle

man P. Novel selective 6 or 5 fatty

acid desaturase inhibitors as antiinflammatory agents in mice. J.

Pharmacol Exp. Ther. 1998;

:157-66.

. [8].Meng L, Mohan R, Kwok BH,

Elofsson M, Sin N ,Crews CM.

Epoxomicin, a potent and selective

proteasome inhibitor,exhibits in vivo

anti-inflammatory activity.

Proc.Natl.Acad.Sci.USA.

;96:10403-8.

. Winter CA, Risley EA, Nuss GW.

Carrageenan induced edema in hind

paw of the rat as an assay for antiinflammatory drugs. Proc. Soc. Exp.

Biol. Med. 1962;111:544-547.

. Armitage P. Statistical methods in

medical assays. 1st. Edn., Black-well

Scientific Publications, London.

; 147.

. Loe H, Silness J. Periodontal

disease in pregnancy. I. Prevalence

and severity. Acta Odontol Scand.

; 21:533-51.

. British Pharmaceutical Codex.1973.

. .Fu B, Li H, Wang X, Lee FS, Cui S.

Isolation and identification of

flavonoids in licorice and a study of

their inhibitory effects on tyrosinase.

J Agric Food Chem.2005; 53:7408-

. Hatano T, Takagi M, Ito H, Yoshida

T. Acylated flavonoid glycosides and

accompanying phenolics from

licorice. Phytochemistry .1998;

:287-293.

. [15].Kase Y, Saitoh K, Ishige A,

Komatsu Y. Mechanisms by which

hange-shashin to reduce

prostaglandin E2 levels. Biol Pharm

Bull.1998; 21: 1277–81.

. Kassir ZA. Endoscopic controlled

trial of four drug regimens in the

treatment of chronic duodenal

ulceration. Ir Med J.1985; 78:153–6.

. Aly AM, Al-Alousi L, Salem HA.

Licorice: a possible antiinflammatory and anti-ulcer drug.

AAPS PharmSciTech.2005; 6:E74–

. Furuhashi I, Iwata S, Shibata S,

Sato T, Inoue H. Inhibition by

licochalcone A, a novel flavonoid

isolated from liquorice root of IL-1β-

induced PGE2 production in human

skin fibroblasts. J Pharm

Pharmacol.2005; 57:1661–6.

. Kang JS, Yoon YD, Cho IJ, Han

MH, Lee CW, Park SK, Kim HM.

Glabridin an isoflavan from licorice

root, inhibits inducible nitric-oxide

synthase expression and improves

survival of mice in experimental

model of septic shock. J Pharmacol

Exp Ther.2005; 312:1187–94.

Downloads

Published

30-09-2012

How to Cite

1.
Nagwa M. Ammar, Siham S.El-Hawary, Amira A.El- anssary, Nagwa Othman, Maha Galal, Ahmed H. El-Desoky. Phytochemical and clinical studies of the bioactive extract of Glycyrrhiza glabra L. Family Leguminosae. ijp [Internet]. 2012 Sep. 30 [cited 2024 Dec. 6];4(3):429-36. Available from: https://ijp.arjournals.org/index.php/ijp/article/view/198

Issue

Section

Original Research Articles